Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim N01 for platelet engraftment and thrombocytopenia after HSCT in children
ChiCTR2500113543Phase 4Not yet recruiting
- Sponsor
- Wuhan Women and Children's Health Care Center
- Start
- Dec 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of romiplostim in Thrombocytopenia (2 arms), sponsored by Wuhan Women and Children's Health Care Center. Primary endpoint: Coagulation function at Day 100. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
romiplostim
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on ChiCTR2500113543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500113543.